Congenica
In the Instand-NGS4P program, a group of seven European hospitals are encouraging technology vendors to innovate by offering a path to IVDR compliance and a wide market for new products.
Congenica Partners With Indian Diagnostics Lab for Genomic Analysis, Reporting
The partnership with Avesthagen subsidiary Avgen Diagnostics seeks to improve sequencing-based diagnostics services in India with rapid NGS analysis.
GenomOncology, Congenica Team up to Develop Precision Oncology Dx Platform
The firms will build on their existing technologies and seek a CE-IVD mark for a new clinical decision support system for individualized cancer therapies.
Apr 12, 2021
Nov 9, 2020
Congenica Closes $50M Series C Funding Round
Apr 30, 2019
Congenica Raises £13.3M in Series B Add-On
Oct 3, 2018